Introduction

"Infection is the
major cause of
implant failure. On
average, 5% of all
biomaterial-implant
patients experience
severe complications,
mainly due to
infection”

The Biomaterials Development Center (BDC) is seeking a number of major device and material companies to invest in a long term partnership to co-develop biomaterials.

By combining the extensive knowledge, facilities and resources of the BDC together with the market knowledge, engineering skills and resources of proven medical device/material companies, we aim to jointly develop new infection-resistant materials for clinical application.

The BDC coordinates and aligns the development of infection-resistant biomaterials from bench to bed using a number of key departments within the University Medical Center Groningen (UMCG) and the University of Groningen (RUG).